{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:17:58Z","timestamp":1780546678327,"version":"3.54.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.path.2010.12.004","type":"journal-article","created":{"date-parts":[[2011,2,23]],"date-time":"2011-02-23T10:03:39Z","timestamp":1298455419000},"page":"375-396","source":"Crossref","is-referenced-by-count":4,"title":["High-Grade Serous Carcinoma Involving Fallopian Tube, Ovary and Peritoneum"],"prefix":"10.1016","volume":"4","author":[{"given":"Osama M.","family":"Al-Agha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Blake Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2010.12.004_bib1","series-title":"World Health Organization classification of tumors. Tumors of the breast and the female genital organs","author":"Tavasolli","year":"2003"},{"key":"10.1016\/j.path.2010.12.004_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.path.2010.12.004_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0002-9378(50)90341-3","article-title":"Primary carcinoma of the fallopian tube","volume":"59","author":"Hu","year":"1950","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.path.2010.12.004_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0039-6109(16)41439-8","article-title":"Carcinoma of the fallopian tube","volume":"58","author":"Sedlis","year":"1978","journal-title":"Surg Clin North Am"},{"issue":"5","key":"10.1016\/j.path.2010.12.004_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00000478-199105000-00001","article-title":"Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei. A clinicopathological analysis of 22 cases supporting an origin in the appendix","volume":"15","author":"Young","year":"1991","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2010.12.004_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.pas.0000152136.81771.12","article-title":"Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms","volume":"29","author":"Elishaev","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"25","key":"10.1016\/j.path.2010.12.004_bib7","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in rimary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.path.2010.12.004_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/IGC.0b013e318199009c","article-title":"The fallopian tube: primary site of most pelvic high-grade serous carcinomas","volume":"19","author":"Salvador","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.path.2010.12.004_bib9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/01.pgp.0000092130.10100.88","article-title":"Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum","volume":"22","author":"Hashi","year":"2003","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"10.1016\/j.path.2010.12.004_bib10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/PAI.0b013e3181ae7240","article-title":"Detection of HPV-DNA by a PCR-based method in formalin-fixed, paraffin-embedded tissue from rare endocervical carcinoma types","volume":"18","author":"Nofech-Mozes","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"2","key":"10.1016\/j.path.2010.12.004_bib11","first-page":"120","article-title":"Serous carcinoma in endometrial polyps","volume":"3","author":"Silva","year":"1990","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2559.2009.03390.x","article-title":"WT1, p53 and hormone receptor expression in uterine serous carcinoma","volume":"55","author":"Hirschowitz","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2010.12.004_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed fallopiantubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":"Risk-reducing salpingooophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy","volume":"1","author":"Powell","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2010.12.004_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":"Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers","volume":"1","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.004_bib16","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.path.2010.12.004_bib17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PAP.0b013e3181b4fffa","article-title":"Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems","volume":"5","author":"Vang","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ygyno.2008.05.010","article-title":"Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma","volume":"3","author":"Salvador","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.004_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation","volume":"2","author":"Singer","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib20","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L","article-title":"Early de novo ovarian carcinoma. A study of fourteen cases","volume":"73","author":"Bell","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.path.2010.12.004_bib21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2559.1995.tb01528.x","article-title":"p53 protein expression in putative precursor lesions of epithelial ovarian cancer","volume":"4","author":"Hutson","year":"1995","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2010.12.004_bib22","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/modpathol.3800827","article-title":"Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary M\u00fcllerian system origin?","volume":"8","author":"Tong","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.pgp.0000130049.19643.f6","article-title":"Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: a report of two cases","volume":"23","author":"Parker","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib24","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/PAS.0b013e31802cbbe9","article-title":"The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis","volume":"7","author":"Dehari","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2559.2009.03283.x","article-title":"High-grade serous carcinoma arising in a low-grade serous carcinoma and micropapillary serous borderline tumor of the ovary in a 23-year-old woman","volume":"54","author":"Quddus","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2010.12.004_bib26","first-page":"663","article-title":"Ovarian serous neoplasms of low malignant potential associated with focal areas of serous carcinoma","volume":"10","author":"Silva","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib27","series-title":"Diagnostic surgical pathology","first-page":"2552","article-title":"Ovarian surface epithelial-stromal tumors","author":"Scully","year":"2004"},{"key":"10.1016\/j.path.2010.12.004_bib28","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/oxfordjournals.aje.a117296","article-title":"Parity, contraception, infertility, and the risk of epithelial ovarian cancer","volume":"7","author":"Risch","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.path.2010.12.004_bib29","first-page":"667","article-title":"Pelvic inflammatory disease and risk of ovarian cancer","volume":"8","author":"Parazzini","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.path.2010.12.004_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/01443610701811894","article-title":"Fallopian tube malignancies: a retrospective clinical pathological study of 17 cases","volume":"1","author":"Liapis","year":"2008","journal-title":"J\u00a0Obstet Gynaecol"},{"key":"10.1016\/j.path.2010.12.004_bib31","series-title":"Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Atlas of tumor pathology","author":"Scully","year":"1992"},{"key":"10.1016\/j.path.2010.12.004_bib32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00000478-200402000-00001","article-title":"Clinicopathologic analysis of early-stage sporadic ovarian carcinoma","volume":"28","author":"Leitao","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib33","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","article-title":"Grading ovarian serous carcinoma using a two-tier system","volume":"4","author":"Malpica","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib34","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/PAS.0b013e31816fd555","article-title":"Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data","volume":"11","author":"Vang","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib35","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/PAS.0b013e318164edf7","article-title":"Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases","volume":"7","author":"Han","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molonc.2009.01.004","article-title":"Intercepting pelvic cancer in the distal fallopian tube: theories and realities","volume":"2","author":"Crum","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1016\/j.path.2010.12.004_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e3181788546","article-title":"A\u00a0limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary","volume":"1","author":"K\u00f6bel","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib38","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1158\/1078-0432.CCR-03-0409","article-title":"Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis","volume":"10","author":"Lu","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.path.2010.12.004_bib39","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/jcp.52.4.283","article-title":"Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin: comparison between a statistical and an intuitive approach","volume":"52","author":"Lagendijk","year":"1999","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib40","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/modpathol.2008.108","article-title":"Immunophenotyping of serous carcinoma of the female genital tract","volume":"9","author":"Nofech-Mozes","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib41","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib42","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","article-title":"Ovarian carcinoma subtypes are different diseases: implications for biomarker studies","volume":"12","author":"K\u00f6bel","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.path.2010.12.004_bib43","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.pgp.0000172083.94934.1e","article-title":"Abnormalities of the RB1 pathway in ovarian serous papillary carcinoma as determined by overexpression of the p16 (INK4A) protein","volume":"24","author":"Armes","year":"2005","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib44","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1365-2559.2007.02682.x","article-title":"High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour","volume":"50","author":"O\u2019Neill","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2010.12.004_bib45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5858\/2008-132-175-IIGP","article-title":"Immunohistochemistry in gynecologic pathology","volume":"2","author":"Deavers","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2010.12.004_bib46","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.pas.0000213369.71676.25","article-title":"p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas","volume":"31","author":"Vang","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib47","doi-asserted-by":"crossref","first-page":"14004","DOI":"10.1073\/pnas.0504195102","article-title":"Amplification of a chromatin remodeling gene, Rsf-1\/HBXAP, in ovarian carcinoma","volume":"102","author":"Shih","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.path.2010.12.004_bib48","doi-asserted-by":"crossref","first-page":"18739","DOI":"10.1073\/pnas.0604083103","article-title":"A\u00a0BTB\/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival","volume":"103","author":"Nakayama","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.path.2010.12.004_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/jcp.55.1.27","article-title":"Morphological effects of chemotherapy on ovarian carcinoma","volume":"1","author":"McCluggage","year":"2002","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib50","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/jcp.2007.053793","article-title":"An immunohistochemical and morphological analysis of post-chemotherapy ovarian carcinoma","volume":"5","author":"Miller","year":"2008","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib51","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.AOG.0000227787.24587.d1","article-title":"Clinical behavior of stage II\u2013IV low-grade serous carcinoma of the ovary","volume":"2","author":"Gershenson","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.path.2010.12.004_bib52","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1525-1438.2007.00820.x","article-title":"Differences of chemoresistance assay between invasive micropapillary\/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma","volume":"3","author":"Santillan","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.path.2010.12.004_bib53","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0002-9440(10)62549-7","article-title":"Diverse tumorigenic pathways in ovarian serous carcinoma","volume":"160","author":"Singer","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib54","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00004347-199607000-00011","article-title":"Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis","volume":"15","author":"Soslow","year":"1996","journal-title":"Int J Gynecol Pathol"},{"issue":"7","key":"10.1016\/j.path.2010.12.004_bib55","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/PAS.0b013e3181962dcd","article-title":"Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma","volume":"33","author":"Lotan","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2007.09.031","article-title":"Society of gynecologic oncologists education committee statement on risk assessment for inherited gynecologic cancer predispositions","volume":"2","author":"Lancaster","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.path.2010.12.004_bib57","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S0046-8177(00)80014-3","article-title":"Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations","volume":"31","author":"Werness","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib58","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jcp.2007.049478","article-title":"My approach to and thoughts on the typing of ovarian carcinomas","volume":"2","author":"McCluggage","year":"2008","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib59","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2559.2004.01787.x","article-title":"WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma","volume":"2","author":"Al-Hussaini","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2010.12.004_bib60","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.pas.0000176429.88702.36","article-title":"Expression of WT1, CA125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary","volume":"29","author":"Tornos","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib61","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2559.1984.tb02336.x","article-title":"Peritoneal epithelial lesions associated with proliferative serous tumors of ovary","volume":"8","author":"McCaughey","year":"1984","journal-title":"Histopathology"},{"key":"10.1016\/j.path.2010.12.004_bib62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2303.2004.00140.x","article-title":"Peritoneal washing cytology","volume":"3","author":"Shield","year":"2004","journal-title":"Cytopathology"},{"issue":"9332","key":"10.1016\/j.path.2010.12.004_bib63","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(02)09738-6","article-title":"Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial","volume":"360","author":"International Collaborative Ovarian Neoplasm Group","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.path.2010.12.004_bib64","first-page":"161","article-title":"Histologic subtypes of ovarian carcinoma: an overview","volume":"2","author":"Soslow","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.pap.0000201826.46978.e5","article-title":"Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer","volume":"1","author":"Lee","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.path.2010.12.004_bib66","doi-asserted-by":"crossref","first-page":"e1000114","DOI":"10.1371\/journal.pmed.1000114","article-title":"The preclinical history of serous ovarian carcinoma: defining the target for early detection","volume":"6","author":"Palmer","year":"2009","journal-title":"PLoS Med"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918110002540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918110002540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T22:48:23Z","timestamp":1740955703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918110002540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1875918110002540"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2010.12.004","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}